Table 1 (abstract A73). Baseline clinical characteristics

Age, years

73 [67-77]

73 [68-77]

0.418

Male sex, n (%)

47 (76)

44 (77)

0.832

BSA, (m2)

1.91[1.78-2.02]

1.85 [1.76-2.01]

0.479

SVS/AAVS, n (%)

0.924

 0

4 (6)

6 (10)

 1

20 (32)

19 (31)

 2

27 (43)

27 (43)

 3

11 (18)

11 (16)

ASA, n (%)

0.188

 1

0

0

 2

6 (10)

2 (3)

 3

44 (71)

42 (68)

 4

12 (19)

18 (29)

Creatinine Clearance, ml/min

59.4[42.0-79.3]

58.8 [46.1-77.8]

0.603

EF,%

60[55-60]

60[55-60]

0.309

Current smoking, n(%)

46 (74)

44 (71)

0.42

Hypertension, n (%)

58 (93)

60 (97)

0.34

Dyslipidemia, n (%)

44 (71)

41 (66)

0.56

Diabetes, n (%)

8 (13)

7 (11)

0.50

Obesity grade, n (%)

0.173

 0

24 (39)

26 (42)

 1

32 (52)

23 (37)

 2

6 (10)

12 (19)

 3

0

0

 4

0

1 (2)

GOLD, n (%)

0.994

 0

21 (34)

21 (34)

 1

26 (42)

24 (39)

 2

12 (19)

14 (23)

 3

2 (3)

2 (3)

 4

1 (2)

1 (2)

NYHA, n (%)

0.866

 I

14 (23)

11 (18)

 II

26 (42)

25 (40)

 III

21 (34)

25 (40)

 IV

1 (2)

1 (2)

Previous PTCA/CABG, n (%)

0.757

 PTCA

17 (27)

19 (31)

 CABG

0

0

 Both

1 (2)

2 (3)

Dialysis, n (%)

4 (6)

0

0.590

Antithrombotic therapy, n (%)

0.298

 None

3 (5)

2 (3)

 Single platelet inhibitors

45 (73)

39 (63)

 Double platelet inhibitors

7 (11)

6 (10)

 Oral anticoagulant

4 (6)

12 (20)

 Antiplatelet/oral anticoagulant

3 (5)

3 (5)